Literature DB >> 19293576

Role of transcription factors in midline central nervous system and pituitary defects.

Daniel Kelberman1, Mehul Tulsidas Dattani.   

Abstract

The anterior pituitary gland is a central regulator of growth, reproduction and homeostasis, and is the end-product of a carefully orchestrated pattern of expression of signalling molecules and transcription factors leading to the development of this complex organ secreting six hormones from five different cell types. Naturally-occurring and transgenic murine models have demonstrated a role for many of these molecules in the aetiology of combined pituitary hormone deficiency (CPHD). These include the transcription factors HESX1, PROP1, POU1F1, LHX3, LHX4, SOX2 and SOX3. The expression pattern of these transcription factors dictates the phenotype that results when the gene encod-ing the relevant transcription factor is mutated. The highly variable phenotype may consist of isolated hypopituitarism, or more complex disorders such as septo-optic dysplasia. Since mutations in any one transcription factor are uncommon, and since the overall incidence of mutations in known transcription factors is low in patients with CPHD, it is clear that many genes remain to be identified, and characterization of these will further elucidate the pathogenesis of these complex conditions, and also shed light on normal pituitary development.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19293576     DOI: 10.1159/000207478

Source DB:  PubMed          Journal:  Endocr Dev        ISSN: 1421-7082


  8 in total

1.  A recessive mutation resulting in a disabling amino acid substitution (T194R) in the LHX3 homeodomain causes combined pituitary hormone deficiency.

Authors:  Susanne Bechtold-Dalla Pozza; Stefan Hiedl; Julia Roeb; Peter Lohse; Raleigh E Malik; Soyoung Park; Mario Durán-Prado; Simon J Rhodes
Journal:  Horm Res Paediatr       Date:  2012-01-26       Impact factor: 2.852

Review 2.  Molecular mechanisms of pituitary organogenesis: In search of novel regulatory genes.

Authors:  S W Davis; F Castinetti; L R Carvalho; B S Ellsworth; M A Potok; R H Lyons; M L Brinkmeier; L T Raetzman; P Carninci; A H Mortensen; Y Hayashizaki; I J P Arnhold; B B Mendonça; T Brue; S A Camper
Journal:  Mol Cell Endocrinol       Date:  2009-12-16       Impact factor: 4.102

3.  A homozygous splice site ROBO1 mutation in a patient with a novel syndrome with combined pituitary hormone deficiency.

Authors:  Sumito Dateki; Satoshi Watanabe; Hiroyuki Mishima; Toshihiko Shirakawa; Minoru Morikawa; Eiichi Kinoshita; Koh-Ichiro Yoshiura; Hiroyuki Moriuchi
Journal:  J Hum Genet       Date:  2019-01-28       Impact factor: 3.172

4.  Whole-exome sequencing identifies homozygous GPR161 mutation in a family with pituitary stalk interruption syndrome.

Authors:  Ender Karaca; Ramazan Buyukkaya; Davut Pehlivan; Wu-Lin Charng; Kursat O Yaykasli; Yavuz Bayram; Tomasz Gambin; Marjorie Withers; Mehmed M Atik; Ilknur Arslanoglu; Semih Bolu; Serkan Erdin; Ayla Buyukkaya; Emine Yaykasli; Shalini N Jhangiani; Donna M Muzny; Richard A Gibbs; James R Lupski
Journal:  J Clin Endocrinol Metab       Date:  2015-01       Impact factor: 5.958

Review 5.  Diagnosis of diseases of steroid hormone production, metabolism and action.

Authors:  John W Honour
Journal:  J Clin Res Pediatr Endocrinol       Date:  2009-08-02

Review 6.  Neonatal screening and a new cause of congenital central hypothyroidism.

Authors:  Toshihiro Tajima; Akie Nakamura; Shuntaro Morikawa; Katsura Ishizu
Journal:  Ann Pediatr Endocrinol Metab       Date:  2014-09-30

7.  A RECURRENT MUTATION IN TSHB GENE UNDERLYING CENTRAL CONGENITAL HYPOTHYROIDISM UNDETECTABLE IN NEONATAL SCREENING.

Authors:  Maria de Fátima Borges; Horacio Mario Domené; Paula Alejandra Scaglia; Beatriz Hallal Jorge Lara; Heloísa Marcelina da Cunha Palhares; Andréia Vasconcelos Aguiar Santos; Amanda Lacerda Ferreira Gonçalves; Marília Matos Oliveira; Alessandra Bernadete Trovó de Marqui
Journal:  Rev Paul Pediatr       Date:  2019-06-03

8.  Genetic and Epigenetic Profiling Reveals EZH2-mediated Down Regulation of OCT-4 Involves NR2F2 during Cardiac Differentiation of Human Embryonic Stem Cells.

Authors:  Varsha Pursani; Prasad Pethe; Mohsin Bashir; Prabha Sampath; Vivek Tanavde; Deepa Bhartiya
Journal:  Sci Rep       Date:  2017-10-12       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.